On August 18 (local time in Brazil), the smart manufacturing project of Linuo Pharmaceutical Packaging Brazil Co., Ltd. officially broke ground. Located in the São Paulo metropolitan area, the project’s first phase covers an area of approximately 5,200 square meters and is expected to enter trial production in October 2026. Upon completion, the facility will serve as Linuo Pharmaceutical Packaging’s manufacturing hub and strategic foothold in South America, strengthening its global industrial footprint while enhancing local service capabilities and market responsiveness.
The São Paulo metropolitan area is a major hub for the economy, industry, and the pharmaceutical sector in Brazil—and indeed all of South America—hosting approximately 60% of Brazil’s pharmaceutical companies. Leveraging the local industrial foundation and strategic location, Linuo Pharmaceutical Packaging aims to deepen collaboration with South American clients and supply chain partners, delivering efficient, reliable, and one-stop high-end pharmaceutical packaging solutions to Brazil and the surrounding markets.
Focusing on specialty glass and building a diversified business portfolio
The project focuses on specialty glass materials and their applications, spanning sectors such as pharmaceutical packaging, heat-resistant glass, and life sciences. With pharmaceutical packaging as its core, the project continuously enhances capabilities in R&D, manufacturing, and integrated services, while actively expanding into cutting-edge areas such as glass substrates and glass-ceramics.
Upon reaching full production capacity, the first phase is projected to yield an annual output of 300 million pharmaceutical glass bottles, with production efficiency and resource allocation benchmarked against advanced international standards. The project’s implementation not only meets the growing demand for high-quality pharmaceutical packaging in the South American market but also further strengthens Linuo Pharmaceutical Packaging’s global competitiveness in the fields of specialty glass and pharmaceutical packaging.
AI-Powered Manufacturing Drives the Global Export of Standardized Capabilities
Unlike traditional overseas capacity deployments, the Brazil project deeply integrates artificial intelligence, digital management, and smart manufacturing technologies. It drives coordinated upgrades across production, quality, operations, and the supply chain, enhancing the automation, digitalization, and precision of the production process to effectively control product quality, production efficiency, and operating costs.
The launch of the Brazil project marks an upgrade in Linuo Pharmaceutical Packaging’s globalization strategy, shifting from the export of standalone products to a multidimensional model comprising an “AI-driven intelligent manufacturing system, technical standards, and localized services.” The company will bring its accumulated expertise in technology, quality, and management to South America, continuously refining its regional operational capabilities by aligning with local customer needs and industry characteristics.
Deeply Cultivating the South American Market, Serving Global Customers
In recent years, the global pharmaceutical supply chain has undergone continuous restructuring, and the South American pharmaceutical market has steadily expanded. These developments have placed higher demands on pharmaceutical packaging companies regarding regional manufacturing, supply reliability, and technical service capabilities. The Brazil project will shorten product delivery distances and enhance supply chain resilience, enabling the provision of more timely, reliable, and professional service support to customers. Since its inception, the project has garnered widespread attention and high expectations from local pharmaceutical companies and partners alike.
The official launch of the Brazil project marks a significant milestone in Linuo Pharma Packaging’s globalization journey and represents a crucial step toward building a world-class enterprise in specialty glass and pharmaceutical packaging. Moving forward, the company will use Brazil as a new starting point to continuously refine its R&D, manufacturing, sales, and service systems across South America. By integrating into the local industrial ecosystem and driving innovation in specialty glass materials and pharmaceutical packaging, Linuo aims to deliver high-quality packaging solutions to the global healthcare industry, backed by advanced intelligent manufacturing and a comprehensive global service network. Transitioning from “Made in China” to “Global Intelligent Manufacturing” and from exporting products to exporting entire operational systems, Linuo Pharma Packaging will continue to expand its global footprint and write a new chapter in its international development.
Preguntas frecuentes
What is the Linuo Pharma Packaging Brazil project?
The Brazil project is a smart manufacturing facility established by Linuo Pharmaceutical Packaging in the São Paulo metropolitan area. It is designed to strengthen local pharmaceutical packaging manufacturing, supply, and service capabilities in South America.
When is the Brazil facility expected to begin production?
The first phase of the project is expected to enter trial production in October 2026.
What is the planned production capacity of the first phase?
After reaching full production capacity, the first phase is projected to produce approximately 300 million pharmaceutical glass bottles per year.
What products and materials will the Brazil project focus on?
The project focuses on specialty glass materials and applications, with pharmaceutical packaging as the core business. It will also cover areas such as heat-resistant glass and life sciences, while exploring emerging fields including glass substrates and glass-ceramics.
How will smart manufacturing be used in the Brazil facility?
The project integrates artificial intelligence, digital management, and smart manufacturing technologies across production, quality management, operations, and the supply chain. The goal is to improve automation, digitalization, production precision, quality control, and operational efficiency.
Why did Linuo Pharma Packaging choose the São Paulo metropolitan area?
The São Paulo metropolitan area is an important economic, industrial, and pharmaceutical hub in Brazil and South America. Its established pharmaceutical industry and strategic location can support closer cooperation with local customers and supply-chain partners.
August 19, 2026 
